Tuberculosis and pregnancy

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 3, 2007, Pages 205-211

  Efferen, Linda S ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Drug toxicity; Latent infection; Multidrug resistant tuberculosis; Pregnancy; Tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; PYRIDOXINE; RIFABUTIN; RIFAMPICIN; RIFAPENTINE; STREPTOMYCIN; THIOACETAZONE; TUBERCULIN;

ACID FAST BACTERIUM; ADD ON THERAPY; BACTERIUM CULTURE; BREAST FEEDING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG SAFETY; EVALUATION; FERTILIZATION IN VITRO; HEPATITIS; HUMAN; INFERTILITY; LIVER DISEASE; LIVER TOXICITY; MATERNAL CARE; MONITORING; MONOTHERAPY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NERVE INJURY; NEWBORN CARE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; OPTIC NEURITIS; PERIPHERAL NEUROPATHY; PREGNANCY; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STAINING; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; UROGENITAL TUBERCULOSIS;

ANTIBODIES, BACTERIAL; ANTITUBERCULAR AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; MYCOBACTERIUM TUBERCULOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; TUBERCULOSIS; WORLD HEALTH;

EID: 34247127013     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3280f6ceee     Document Type: Review

References (41)

1. Arias E, Smith BL. Deaths: preliminary data for 2001. Natl Vital Stat Rep 2003; 51:1-44.
2. Vo QT, Stettler W, Crowley K. Pulmonary tuberculosis in pregnancy. Prim Care Update Ob Gyns 2000; 7:244-249.
3. Thillagavathie P. Current issues in maternal and perinatal tuberculosis: impact of the HIV-1 epidemic. Semin Neonal 2000; 5:189-196.
4. Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001; 345:189-200.
5. Sabbatini S, Baldi E, Manfredi R, Chiodo F. Admission of foreign citizens to the general teaching hospital of Bologna, Northeastern Italy. A nepidemiological and clinical survey. Braz J Infect Dis 2006; 10:66-77. An interesting paper which provides specific information about a singlemunicipality's experiences, which are pertinent to all.
6. de la Torre J, Coll C, Coloma M, et al. Antenatal care in immigrants. An Sist Sanit Navar 2006; 29 (Suppl 1):49-61. (In Spanish).
7. Zvandasara P, Hargrove JW, Ntozini R, et al. Mortality and morbidity among postpartum HIV-positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin A supplementation. J Acquir Immune Defic Syndr 2006; 43:107-116. A 'negative' study with respect to efficacy of vitamin A supplementation, this large cohort provides sobering information on the deadly impact of HIV and TB in postpartum women.
8. Vallejo JG, Starke JR. Tuberculosis and pregnancy. Clin Chest Med 1992; 13:693-707.
9. Figueroa-Damian R, Arredondo-Garcia JL. Neonatal outcome of children born to women with tuberculosis. Arch Med Res 2001; 32:66-69.
10. Kothari A, Mahadevan N, Girling J. Tuberculosis and pregnancy: Results of a study in a high prevalence area in London. Eur J Obstet Gynecol Reprod Biol 2006; 126:48-55. An excellent study detailing the incidence and clinical experience from a cohort of patients with tuberculosis during pregnancy over a 5 year period in a high prevalence area in London, UK.
11. Bothamley G. Drug treatment for tuberculosis during pregnancy. Drug Saf 2001; 24:553-565.
12. Llewelyn M, Cropley I, Wilkinson RJ, Davidson RN. Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax 2000; 55:129-132.
13. American Thoracic Society Official Statement. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161:S221-S247.
14. American Thoracic Society Official Statement. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161:1376-1395.
15. Eriksen NL, Helfgott AW. Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus. Infect Dis Obstet Gynecol 1998; 6:13-17.
16. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection. An interferon-γ-based assay using new antigens. Am J Respir Crit Care Med 2004; 170:59-64.
17. Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 2006; 3:103-110. An excellent review of current options for the diagnosis of LTBI, active TB and detection of drug resistance.
18. CDC. Notice regarding indeterminate results with the QuantiFERON-TB Gold test. http://www.cdc.gov/nchstp/tb/QuantiferonTBGoldTestNotice.htm. Accessed 12/8/2006.
19. Efferen L. Tuberculosis Update: Will good news become bad news? Curr Opin Pulm Med 1997; 3:131-138.
20. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection. 2006 recommendations of the international AIDS Society-USA Panel. JAMA 2006; 296:827-843. Excellent summary of current recommendations for treatment, including antiretroviral therapy in special populations inclusive of pregnancy and tuberculosis.
21. Tripathy SN, Tripathy SN. Tuberculosis and pregnancy. Int J Gynaecol Obstet 2003; 80:247-253.
22. Shin S, Guerra D, Rich M, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: A report of 7 cases. Clin Infect Dis 2003; 36:996-1003.
23. Lessnau K-DKL, Qarah S. Multidrug resistant tuberculosis in pregnancy. Case report and review of the literature. Chest 2003; 123:953-956; (Additional case report not included in Ref. [21]).
24. Drobac PC, delCastillo H, Sweetland A, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis 2005; 40:1689-1692.
25. Takashima T, Danno K, Tamura Y, et al. Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy (in Japanese). Kekkaku 2006; 81:413-418. Three additional cases reported of successful treatment of MDRTB with second line agents with good maternal and neonatal outcomes.
26. Boggess KA, Myers ER, Hamilton CD. Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. Obstet Gynecol 2000; 96:757-762.
27. Franks AL, Binkin NJ, Snider DE Jr, et al. Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Rep 1989; 104:151-155.
28. Kopanoff DE, Snider DE Jr, Caras GJ. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117:991-1001.
29. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: A 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281:1014-1018.
30. Fountain FF, Tolet E, Chrisman CR, Self TH. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection. A 7-year evaluation from a public health tuberculosis clinic. Chest 2005; 128:116-123.
31. Wilson EA, Thelin TJ, Ditts PV Jr. Tuberculosis complicated by pregnancy. Am J Obstet Gynecol 1973; 115:526-529.
32. Snider DE Jr, Layde PM, Johnson MW, et al. Treatment of tuberculosis in pregnancy. Am Rev Respir Dis 1980; 122:65-79.
33. Cruz CA, Caughey AB, Jasmer R. Postpartum follow-up of a positive purified protein derivative (PPD) among an indigent population. Am J Obstet Gynecol 2005; 192:1455-1457.
34. Sackoff JE, Pfeiffer MR, Driver CR, et al. Tuberculosis prevention for non-US-born pregnant women. Am J Obstet Gynecol 2006; 194:451-456. Comparable data to that presented by Cruz et al. [33] from an at risk population on the East Coast (New York City).
35. Sangala WT, Briggs P, Theobold S, et al. Screening for pulmonary tuberculosis: an acceptable intervention for antenatal care clients and providers? Int J Tuberc Lung Dis 2006; 107:789-794.
36. Goldberg SV, Wallace J, Jackson JC, et al. Cultural case management of latent tuberculosis infection. Int J Tuberc Lung Dis 2004; 8:76-82.
37. Lawrence RM, Lawrence RA. The evidence for breastfeeding. Pediatr Clin North Am 2001; 48:235-251.
38. Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001; 56:494-499.
39. Rie AV, Madhi SA, Heera JR, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006; 13:246-252.
40. Gurgan T, Urman B, Yarali H. Results of in vitro fertilization and embryo transfer in women with infertility due to genital tuberculosis. Fertil Steril 1996; 65:367-370.
41. Dam P, Shirazee HH, Goswami SK, et al. Role of latent genital tuberculosis in repeated IVF failure in the Indian clinical setting. Gynecol Obstet Invest 2006; 61:223-227.